Scopus h-index:30
- Home
- Profiles
Accepting New Patients
Mount Sinai Doctors
Accepting New PatientsAlan B Copperman, MD
Obstetrics and Gynecology (OBGYN), Reproductive Endocrinology
No Patient Experience Ratings
Reproductive Medicine Associates of New York
212-756-5777
- About Me
- Clinical Focus
- Education & Certifications
- Awards
- Locations
- Insurance
- Publications
- Industry Relationships
About Me
Alan B. Copperman, MD, FACOG, serves as Division Director of Reproductive Endocrinology and Infertility and is a Clinical Professor in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Copperman is also the Managing Director and CEO of RMA of New York. As an experienced and respected clinician leveraging research, practicing data-driven medicine, and prioritizing patient centered-care for more than 25 years, Dr. Copperman is world-renowned for his consistent contributions to the field of reproductive medicine.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Alan B. Copperman, MD, FACOG, serves as Division Director of Reproductive Endocrinology and Infertility and is a Clinical Professor in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Copperman is also the Managing Director and CEO of RMA of New York. As an experienced and respected clinician leveraging research, practicing data-driven medicine, and prioritizing patient centered-care for more than 25 years, Dr. Copperman is world-renowned for his consistent contributions to the field of reproductive medicine.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Alan B. Copperman, MD, FACOG, serves as Division Director of Reproductive Endocrinology and Infertility and is a Clinical Professor in the Raquel and Jaime Gilinski Department of Obstetrics, Gynecology and Reproductive Science at the Icahn School of Medicine at Mount Sinai. Dr. Copperman is also the Managing Director and CEO of RMA of New York. As an experienced and respected clinician leveraging research, practicing data-driven medicine, and prioritizing patient centered-care for more than 25 years, Dr. Copperman is world-renowned for his consistent contributions to the field of reproductive medicine.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- Donor Egg
- Donor Sperm
- Egg Freezing
- Embryo Genetic Testing
- Endometriosis
- Female Infertility
- Fertility
- Fertility Counseling
- Fertility Preservation
Show More
- Donor Egg
- Donor Sperm
- Egg Freezing
- Embryo Genetic Testing
- Endometriosis
- Female Infertility
- Fertility
- Fertility Counseling
- Fertility Preservation
- Fertility Testing
- Fibroids
- Gay, Lesbian, Bisexual, Transgender Services
- Genetic Counseling
- Genetic Screening
- Gestational Carrier/Surrogate
- Hormone Disorders
- Hysteroscopy
- IVF / Reproductive Endocrinology
- IVF Counseling
- Implantation
- Implantation of Fertilized Egg(s)
- In Vitro Fertilization
- Infertility
- Infertility In Women
- LGBTQ+ Family-Building
- Laparoscopy
- Miscarriage
- Myomectomy
- Oncofertility
- PGT (Preimplantation Genetic Testing)
- Recurrent Pregnancy Loss
- Reproductive Surgery
- Semen Analysis
- Uterine Fibroids
Education
MD, New York Medical College
Residency, OB/GYN
Yale-New Haven Hospital
Fellowship, Repro. Endocrinology
The Mount Sinai Hospital
Awards
2022
Notable Health Care Leader
Crain's New York
2008-2022
New York Super Doctor
Top Doctors
Castle Connolly New York Magazine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Article:94
Review Article:10
Comment/Debate:2
Letter:11
Editorial:1
Chapter:4
Recent Artifacts
- Association of Myomectomy With Anti-Müllerian Hormone Levels and Ovarian Reserve
- An interpretable machine learning model for individualized gonadotrophin starting dose selection during ovarian stimulation
- Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data
- Pathways to fatherhood: clinical experiences with assisted reproductive technology in single and coupled intended fathers
- Elevated Body Mass Index in Donor Oocyte Recipients Does Not Affect Implantation of Euploid Embryos
- Biological relevance of trophectoderm morphology: initial β-hCG measurements correlate with trophectoderm grading on euploid frozen embryo transfers
- An interpretable machine learning model for predicting the optimal day of trigger during ovarian stimulation
- In Vitro Fertilization and Early Pregnancy Outcomes After Coronavirus Disease 2019 (COVID-19) Vaccination
- Evaluating in vitro fertilization outcomes of patients with low body mass index following frozen-thawed embryo transfer
- Factors associated with vitrification-warming survival in 6167 euploid blastocysts
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Copperman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- RMANY
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Progyny
- Sema4
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.